Araccel wins $600,000 contract for eClinical Trial Solution

Araccel revealed a key component of its software and services in these electronic trials is the ability to integrate handheld computer devices, phone server and ASPlatform capabilities in order to con



Araccel revealed a key component of its software and services in these electronic trials is the ability to integrate handheld computer devices, phone server and ASPlatform capabilities in order to convert paper documentation into electronic databases for these projects.

"I am very pleased with the increased market reception of ASPlatform and the recently introduced ASPocketTrial," said Jim Conklin, MD, CEO of Araccel Group. The strength of our solution lies in its fully integrated modular component and platform capabilities. The recent success in selling our new technology solutions is based on our global experience and proven success getting new drugs approved. Araccel has supported ten approved drugs that are now on the market.